| Case (COV-HD+ COV groups) | Control (HD group) | P Value |
---|---|---|---|
Number | 60 | 40 | Â |
Gender | |||
 Male | 30 (50) | 17 (42.5%) | 0.54 a |
 Female | 30 (50) | 23 (57.5%) | |
CBC differential counts | |||
 Hemoglobin (mg/dl) | 10.3 (6.5–17.6) | 10.1 (7.7–14.8) | 0.28 a |
 Total WBCs (cell/ μl) | 7600 (3200–22,500) | 6350 (2300–10,200) | 0.02 a |
 Neutrophil (cell/ μl) | 5402 (2080–18,225) | 3270 (782–6796) | < 0.001 a |
 Lymphocyte (cell/ μl) | 1137 (480–5000) | 1722 (665–3276) | 0.002 a |
 NL ratio (%) | 3.44 (1.44–21.7) | 1.88 (0.7–4.99) | < 0.001 a |
Flowcytometry counts | |||
 CD4+ T cells (cell/ μl) | 45.1 (1.9–397.6) | 125.2 (7.36–1162.9) | 0.001 a |
 Tregs (cell/ μl) | 0.016 (0–5.77) | 0.28 (0–140.9) | < 0.001 a |
 CD39+ Tregs (cell/ μl) | 0.0031 (0–5.6) | 0.049 (0–135.3) | 0.001 a |